Approval · Notice of Compliance 8178 · 2006
FENOMAX: Notice of Compliance 8178
Issued July 27, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8178
- Date
- July 27, 2006
- Company
- Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Product name change from fenofibrate capsules
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- LIPIDIL SUPRA (Laboratoires Fournier S.A.S.)
Products in this notice
Medicinal ingredients
- FENOFIBRATE 100 MG per CAP
- FENOFIBRATE 160 MG per CAP